The story AT&T’s Q1 earnings don’t tell about HBO Max

AT&T’s streaming service, on which it’s betting billions of dollars, reported a strong first quarter, helped in part by Godzilla vs. Kong, a mega-budget film from AT&T’s Warner Bros. studio. Even AT&T bear Craig Moffett, an analyst who has a sell rating on the stock, acknowledged that HBO Max’s latest results “were better than just…

The overlooked report from the U.S. Treasury you should know about

Devoted consumers of Washington news face a growing cognitive danger: billions-and-trillions overload. In mere weeks we’ve had to get a grip on a pandemic relief bill ($1.9 trillion), a proposed infrastructure bill ($2.2 trillion), and a new White House budget request ($1.5 trillion), with a complete proposed federal budget (to be determined, in the trillions)…

Derek Chauvin was found guilty. What will companies say about it?

Many major companies and CEOs spoke out after George Floyd was killed last May. How many will respond to Derek Chauvin’s conviction on charges of murdering him? Companies now face a dilemma that they didn’t face then. Over the past few years, employees and the public have come to expect companies to take positions on…

Bernie Madoff and the disorienting mix of motives that led to history’s largest Ponzi scheme

Everyone seems to agree that Bernie Madoff, who died this morning in prison, was evil. And he was. But he was evil in a strange way that doesn’t fit any conventional conception of the term. His disorienting mixture of occasional concern for others and deeply ingrained lying, of legitimately earned respectability and the coldest-hearted malevolence…

Leadership lessons J&J should—and shouldn’t—take from its famous Tylenol response

“This is loony. This is crazy,” says Arthur Caplan, founding head of the Division of Medical Ethics at NYU School of Medicine in New York City. He’s talking about Tuesday’s joint statement from Dr. Anne Schuchat of the Food and Drug Administration and Dr. Peter Marks of the Centers for Disease Control and Prevention regarding…

The latest partisan issue: Whether CEOs should speak up on social issues

If America’s high-profile CEOs didn’t already realize they can’t win by taking public positions on controversial issues, they certainly realize it now. Trouble is, they also can’t win by declining to take positions. The corporate public relations crisis surrounding Georgia’s new election law is just the latest example of the quandary CEOs face, this time…

Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?

As talk of reform grows in D.C., the two sides are gearing up for an epic clash.   “It’s just appalling,” says Molly Smith, group vice president for public policy at the American Hospital Association. She’s talking about a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA). “Hospitals’ Practices Increase Costs of…

How much infrastructure is in Biden’s infrastructure plan?

How much of the Biden administration’s big infrastructure plan is about infrastructure? Some Republican critics contend that hardly any of it is. “Only about 5% to 7% of it is roads and bridges and ports and things that you I would say is real infrastructure,” Russell Vought, President Trump’s director of the Office of Management…

The rising interest in a wealth tax

After years of talk, a powerful head of steam is building behind the idea of a wealth tax on the very rich. Could it actually happen? While President Biden didn’t include it as a funding mechanism in his new $2 trillion infrastructure plan, White House press secretary Jen Psaki earlier in March pointedly refused to…